Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
Moreover, because carnitine also offers antioxidant and anti-inflammatory effects, it has been shown to reduce markers of vascular injury in patients undergoing hemodialysis and in those with peripheral vascular disease (11, 12)
Lethargy and reduced energy peak 24 hours post-dose, which is why nighttime administration is standard
This underscores the need for both RWE and RCTs in parallel and reinforces the need to need to run clinical trials that reflect real-world populations, a topic explored in more detail in our blog Obesity trials on trial Some health improvement seen with GLP-1 therapy may be a direct effect of weight loss, rather than unique drug effect as seen by improvements in liver and kidney health 4
Dysfunctional ETC, in turn, further enhances ROS production and increases the disruption of the mitochondrial respiratory function and mitochondrial integrity [129]
For those interested in exploring peptide therapies, focusing on well-studied options like BPC 157 powder may be a more prudent approach